Xiaoming Yang
Corporate Officer/Principal at TRANSCENTA HOLDING LIMITED
Profile
Xiaoming Yang's current job is as an Executive VP-Process & Product Development at Transcenta Holding Ltd.
Dr. Yang's former jobs include being a Scientific Director-Process & Product Development at Amgen, Inc. from 2003 to 2013, and being the Head-Commercial Production at Allergan Ltd.
(Ireland) from 2001 to 2003.
Dr. Yang's education history includes a doctorate degree from Rutgers State University of New Jersey in 2001, an undergraduate degree from Chengdu University of Science & Technology in 1984, and an undergraduate degree from the Institute of Process Engineering in 1987.
Xiaoming Yang active positions
Companies | Position | Start |
---|---|---|
TRANSCENTA HOLDING LIMITED | Corporate Officer/Principal | 2021-01-31 |
Former positions of Xiaoming Yang
Companies | Position | End |
---|---|---|
AMGEN INC. | Corporate Officer/Principal | 2013-05-31 |
ALLERGAN PLC | Corporate Officer/Principal | 2003-05-31 |
Training of Xiaoming Yang
Rutgers State University of New Jersey | Doctorate Degree |
Chengdu University of Science & Technology | Undergraduate Degree |
Institute of Process Engineering | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
AMGEN INC. | Health Technology |
TRANSCENTA HOLDING LIMITED | Health Technology |
Private companies | 1 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Xiaoming Yang